Company: CRL
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001100682-25-000011
Chunk: 133

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 133
---
)(7,761)Net cash used in financing activities(550,927)(85,521)(42,397)Effect of exchange rate changes on cash, cash equivalents, and restricted cash(17,474)8,044 25,579 Net change in cash, cash equivalents, and restricted cash(78,910)43,266 (5,100)Cash, cash equivalents, and restricted cash, beginning of period284,480 241,214 246,314 Cash, cash equivalents, and restricted cash, end of period$205,570 $284,480 $241,214 See Notes to Consolidated Financial Statements.

62

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS(in thousands) 

Redeemable Noncontrolling InterestsCommon stockAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive Income (Loss)Treasury StockTotal EquityAttributableto CommonShareholdersNoncontrollingInterestTotalEquitySharesAmountSharesAmountDecember 25, 2021$53,010 50,480 $505 $1,718,304 $980,751 $(164,740)— $— $2,534,820 $4,162 $2,538,982 Net income4,020 — — — 486,226 — — — 486,226 2,362 488,588 Other comprehensive (loss)(3,585)— — — — (97,317)— — (97,317)— (97,317)Dividends declared to noncontrolling interest(3,525)— — — — — — — — (1,739)(1,739)Purchase of redeemable noncontrolling interest(15,000)— — — — — — — — — — Adjustment to noncontrolling interest fair value7,507 — — (7,507)— — — — (7,507)— (7,507)Issuance of stock under employee compensation plans— 594 5 25,100 — — — — 25,105 — 25,105 Purchase of treasury shares— — —